Targeting Mitochondria In Aging-Related Diseases: Therapeutic Potential And Obstacles
Our cells rely on tiny powerhouses called mitochondria to generate energy and maintain overall health. As we age, these vital organelles can start to falter, leading to a decline in their ability to produce energy, manage their own quality control (a process called mitophagy, where damaged mitochondria are removed), and maintain the stability of their genetic material (mitochondrial DNA). This age-related decline in mitochondrial function is not just a sign of getting older; it actively contributes to a range of common diseases, including those affecting our muscles, bones, brain (neurodegeneration), heart and blood vessels (cardiovascular), and metabolism.
Researchers are exploring various strategies to counteract this decline. These include approaches that aim to improve how mitochondria use energy, interventions tailored to specific diseases, and cutting-edge technologies like transplanting healthy mitochondria or editing their DNA. While these therapeutic avenues hold great promise, there are challenges to overcome, such as understanding how mitochondrial function varies in different tissues throughout the body. Beyond these advanced techniques, simpler interventions like caloric restriction (eating less), regular exercise, and certain medications such as metformin, rapamycin, and resveratrol have also shown potential in supporting mitochondrial health and function.
Source: link to paper